(Q53561569)

English

World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.

scientific article published in May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

0 references

World Health Organization

1 reference

based on heuristic

inferred from title

Catherine Klersy

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

Paolo Bernasconi

object named as

Paolo Bernasconi

1

0 references

author name string

Marina Boni

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

Paola M Cavigliano

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

Silvia Calatroni

5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

Ilaria Giardini

6

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

Barbara Rocca

7

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

Rita Zappatore

8

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

Marilena Caresana

9

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

Irene Dambruoso

10

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

Mario Lazzarino

11

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

Carlo Bernasconi

12

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

language of work or name

0 references

publication date

1 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

137

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

193-205

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

Evaluating the prognosis of patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06537.X

21 January 2018

A comparative review of classification systems in myelodysplastic syndromes (MDS).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06537.X

21 January 2018

Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06537.X

21 January 2018

Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institution.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06537.X

21 January 2018

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06537.X

21 January 2018

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06537.X

21 January 2018

Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06537.X

21 January 2018

Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06537.X

21 January 2018

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06537.X

21 January 2018

Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15-20% of cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06537.X

21 January 2018

The cytogenetics of myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06537.X

21 January 2018

Deletion (11)(q13) as the sole anomaly in myeloid malignancies: four new cases and a short review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06537.X

21 January 2018

Myelodysplastic syndrome: a search for minimal diagnostic criteria.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06537.X

21 January 2018

Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06537.X

21 January 2018

Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06537.X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06537.X

21 January 2018

The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06537.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2007.06537.X

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17408458

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53561569&oldid=1301312859"